PHILADELPHIA, Pennsylvania, Nov. 6 -- Molecular Cancer Therapeutics, a journal from the American Association for Cancer Research that publishes focuses on discovery and preclinical developments of novel therapeutic agents for oncology, preclinical studies of approved therapeutics, mechanisms of drug action, mechanisms of drug resistance, biomarkers of drug response, novel models and technologies and drug toxicity mechanisms, published research articles on the following topics in its November 202 . . .

Click here for more information about our products